If passed, SB1906 would create a structured regulatory framework for zootechnical animal food substances, facilitating their safe use in animal feed. The bill mandates that any such substances must not be used for the diagnosis or treatment of animal diseases but focuses on their effect on digestion and pathogen reduction. For manufacturers, this could lead to more straightforward pathways for introducing new products to market while ensuring compliance with public health standards.
Summary
SB1906, officially titled the Innovative Feed Enhancement and Economic Development Act of 2025, introduces significant amendments to the Federal Food, Drug, and Cosmetic Act regarding the regulation of zootechnical animal food substances. The bill seeks to define zootechnical animal food substances, which are intended to affect the digestive process in animals or reduce foodborne pathogens that pose a risk to human health. By classifying these substances under specified categories and delineating their intended functions, the bill aims to clarify the regulatory landscape for manufacturers and users of these products.
Contention
Notably, concerns may arise around the interpretation of what constitutes a zootechnical animal food substance, particularly in distinguishing it from other food additives and drugs. Critics may argue that without clear guidelines and oversight, there could be risks associated with food safety and animal health. Furthermore, the effectiveness of the proposed regulatory changes in ensuring consumer safety while promoting innovation in animal feed has the potential to be a point of contention among stakeholders in the agricultural and food safety communities.
Expanded Food Safety Investigation Act of 2025This bill provides that the Food and Drug Administration (FDA) may, under specified circumstances, request access to a concentrated animal-feeding operation (i.e., a stabled or confined animal-feeding operation of a specified size) to conduct microbial sampling.Specifically, the bill allows the FDA to request access if the FDA determines that sampling is necessary to facilitate an investigation of a foodborne-illness outbreak, determine the cause of an outbreak, or address other public health needs. Concentrated animal-feeding operations must provide reasonable access for sampling, including sampling of plants, animals, water, and the environment. The bill imposes penalties on operations that refuse to provide reasonable access. Data collected in sampling efforts under this bill must be shared with the Department of Agriculture and state and federal public health agencies to facilitate the detection, investigation, and prevention of foodborne illness.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25